Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data

BACKGROUND: Proteinuria is a common adverse effect of vascular endothelial growth factor targeted agents, particularly in metastatic renal cell carcinoma (mRCC). However, risk factors for proteinuria are poorly defined. METHODS: Data on 1392 mRCC patients using pazopanib or sunitinib were pooled fro...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Cancer
Main Authors: Sorich, Michael J, Rowland, Andrew, Kichenadasse, Ganessan, Woodman, Richard J, Mangoni, Arduino A
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2016
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984472/
https://ncbi.nlm.nih.gov/pubmed/27228299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.147
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker